Clinical Trials Browser

Breast Neoplasms

NCT01351805 2025-12-03

VITAL

Phase NA Completed

25,871 enrolled 15 charts

Arthritis, Rheumatoid, Autoimmune Diseases, Osteoarthritis, Psoriasis

NCT06055894 2025-11-13

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

Phase NA Recruiting

200 enrolled

Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

NCT00244816 2025-10-23

Taxoprexin® Treatment for Advanced Eye Melanoma

Phase 2 Completed

22 enrolled

Dermatologic

Melanoma

NCT00422877 2025-10-16

Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract

Phase 2 Terminated

13 enrolled

Gastrointestinal

Liver Neoplasms

NCT00249262 2025-09-26

Taxoprexin Treatment for Advanced Skin Melanoma

Phase 2 Completed

30 enrolled

Dermatologic

Melanoma

NCT02295059 2025-09-16

Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention

Phase NA Active not recruiting

80 enrolled

Breast

Breast Neoplasms

NCT07136519 2025-08-22

Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma

Phase 2 Not yet recruiting

30 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT00243867 2025-08-01

Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer

Phase 3 Completed

518 enrolled 16 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07036952 2025-07-24

Effect of Omega-3 Supplementation as Add on Therapy on Metabolic Syndrome in Women With Polycystic Ovary Syndrome.

Phase NA Enrolling by invitation

68 enrolled

Polycystic Ovary Syndrome

NCT00087776 2025-07-23

Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma

Phase 3 Terminated

393 enrolled

Dermatologic

Melanoma

NCT03831178 2025-06-26

DHA-WIN

Phase 2 Active not recruiting

76 enrolled

Breast

Breast Neoplasms

NCT06015971 2025-05-06

Omega-3 Fatty Acids and Nutritional Support in Gastrointestinal Cancer

Phase NA Recruiting

40 enrolled

Neoplasms, Sarcopenia

NCT06928701 2025-04-15

NEOMET

Phase NA Recruiting

160 enrolled

Breast

Breast Neoplasms

NCT06918080 2025-04-09

Hepatoprotective Measures for Children at High Risk of NAFLD

Phase 4 Active not recruiting

200 enrolled

LymphoidOtherOther hematologic neoplasm

Obesity, Overweight, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Non-alcoholic Fatty Liver Disease

NCT02521753 2025-04-01

OMgObPCOS

Phase NA Terminated

123 enrolled

Other

Obesity, Polycystic Ovary Syndrome

Clinical Trials

Window of Opportunity Study Targeting the Inflammatory Milieu

VITAL

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

Taxoprexin® Treatment for Advanced Eye Melanoma

Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract

Taxoprexin Treatment for Advanced Skin Melanoma

Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention

Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma

Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer

Effect of Omega-3 Supplementation as Add on Therapy on Metabolic Syndrome in Women With Polycystic Ovary Syndrome.

Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma

DHA-WIN

Omega-3 Fatty Acids and Nutritional Support in Gastrointestinal Cancer

NEOMET

Hepatoprotective Measures for Children at High Risk of NAFLD

OMgObPCOS